Clinical Trial

Efficacy and Safety of DEB-TACE Combined With HAIC Versus HAIC Alone in Patients With Unresectable CRLM

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 22, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Retrospective evaluation of the efficacy and safety of DEB-TACE combined with HAIC versus HAIC alone in patients with unresectable colorectal liver metastases (CRLM)
Trial Details
NCT Number NCT07031570
Lead Sponsor Peking University Cancer Hospital & Institute
Conditions Colorectal Cancer Metastatic
Enrollment 500 participants
Start Date 2025-07-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-22